Levocetirizine Dihydrochloride Tablet
Product Images NDC 31722-551

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Levocetirizine Dihydrochloride (NDC 31722-551). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Camber1

FDA Label Image

Label

Packaging label for Levocetirizine Dihydrochloride Tablets USP 5 mg, manufactured by Camber Pharmaceuticals, Inc. The label indicates an NDC of 31722-551-30 and contains 30 tablets. The label includes dosage strength, manufacturer information, a U.S. contact number, storage instructions, and a child-resistant closure warning.*

FDA Label Image

Levocitirizine5mg30scount

Label for Levocetirizine Dihydrochloride Tablets, USP 5 mg by Camber Pharmaceuticals, Inc. The label states the product contains 30 tablets, prescription only, with storage instructions and a U.S. contact number. The label includes a barcode and manufacturing information from Annora Pharma Pvt. Ltd., India.*

FDA Label Image

Levocitirizinestructure

Chemical structure of Levocetirizine Dihydrochloride, showing the molecular arrangement including chlorine-substituted aromatic rings, a piperazine ring, and carboxylic acid functional groups with dihydrochloride notation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.